Replies to post #55701 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

It's a nice article. Optune is not standard of care (yet) in nGBM -- read their SEC statements on their efforts to make it widely accepted and their concerns it may not achieve that status. However, the journalist feels it is "incorporating" into SOC. Personally I think you're a bit system oriented when you appreciate/enjoy small incremental progress, if one accepts the phase III Optune results of 2.8 months in the ITT group, can potentially block much larger advances in medical progress, but hey, whatever floats your boat. Regardless, it is a different method of action -- which distinguishes it from "available therapy" for purposes of AA, IMHO.